{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:52:25Z","timestamp":1785786745678,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:00:00Z","timestamp":1682121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:00:00Z","timestamp":1682121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s11060-023-04312-8","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T12:01:50Z","timestamp":1682164910000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The abscopal effect: inducing immunogenicity in the treatment of brain metastases secondary to lung cancer and melanoma"],"prefix":"10.1007","volume":"163","author":[{"given":"Jovanna A.","family":"Tracz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna M.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Ngu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morana","family":"Vojnic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.Gabriella","family":"Wernicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy S.","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,22]]},"reference":[{"key":"4312_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011061","author":"JR Janopaul-Naylor","year":"2021","unstructured":"Janopaul-Naylor JR, Shen Y, Qian DC, Buchwald ZS (2021) The Abscopal Effect: a review of pre-clinical and clinical advances. Int J Mol Sci https:\/\/doi.org\/10.3390\/ijms222011061","journal-title":"Int J Mol Sci"},{"key":"4312_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.currproblcancer.2015.10.001","volume":"40","author":"Y Abuodeh","year":"2016","unstructured":"Abuodeh Y, Venkat P, Kim S (2016) Systematic review of case reports on the abscopal effect. Curr Probl Cancer 40:25\u201337","journal-title":"Curr Probl Cancer"},{"key":"4312_CR3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/COC.0000000000000623","volume":"42","author":"MA D\u2019Andrea","year":"2019","unstructured":"D\u2019Andrea MA, Reddy GK (2019) Extracranial abscopal effects induced by brain radiation in advanced lung cancer. Am J Clin Oncol 42:951\u2013957","journal-title":"Am J Clin Oncol"},{"key":"4312_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/CMR.0000000000000386","volume":"27","author":"A Aboudaram","year":"2017","unstructured":"Aboudaram A, Modesto A, Chaltiel L et al (2017) Concurrent radiotherapy for patients with metastatic melanoma and receiving anti-programmed-death 1 therapy: a safe and effective combination. Melanoma Res 27:485\u2013491","journal-title":"Melanoma Res"},{"key":"4312_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/03008916211004733","volume":"108","author":"M Bassanelli","year":"2022","unstructured":"Bassanelli M, Ricciuti B, Giannarelli D et al (2022) Systemic effect of radiotherapy before or after nivolumab in lung cancer: an observational, retrospective, multicenter study. Tumori 108:250\u2013257","journal-title":"Tumori"},{"key":"4312_CR6","doi-asserted-by":"publisher","first-page":"e1046028","DOI":"10.1080\/2162402X.2015.1046028","volume":"4","author":"RA Chandra","year":"2015","unstructured":"Chandra RA, Wilhite TJ, Balboni TA et al (2015) A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab. Oncoimmunology 4:e1046028","journal-title":"Oncoimmunology"},{"key":"4312_CR7","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/ijc.32934","volume":"147","author":"E Funck-Brentano","year":"2020","unstructured":"Funck-Brentano E, Baghad B, Fort M et al (2020) Efficacy of late concurrent hypofractionated radiotherapy in advanced melanoma patients failing anti-PD-1 monotherapy. Int J Cancer 147:1707\u20131714","journal-title":"Int J Cancer"},{"key":"4312_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000497211","volume":"42","author":"G Galli","year":"2019","unstructured":"Galli G, Cavalieri S, Di Guardo L et al (2019) Combination of Immunotherapy and Brain Radiotherapy in metastatic melanoma: a retrospective analysis. Oncol Res Treat 42:186\u2013194","journal-title":"Oncol Res Treat"},{"key":"4312_CR9","doi-asserted-by":"publisher","first-page":"e28780","DOI":"10.4161\/onci.28780","volume":"3","author":"AM Grimaldi","year":"2014","unstructured":"Grimaldi AM, Simeone E, Giannarelli D et al (2014) Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy. Oncoimmunology 3:e28780","journal-title":"Oncoimmunology"},{"key":"4312_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/15384047.2016.1264543","volume":"18","author":"KM Koller","year":"2017","unstructured":"Koller KM, Mackley HB, Liu J et al (2017) Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone. Cancer Biol Ther 18:36\u201342","journal-title":"Cancer Biol Ther"},{"key":"4312_CR11","doi-asserted-by":"publisher","first-page":"e1442166","DOI":"10.1080\/2162402X.2018.1442166","volume":"7","author":"A Roger","year":"2018","unstructured":"Roger A, Finet A, Boru B et al (2018) Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients. Oncoimmunology 7:e1442166","journal-title":"Oncoimmunology"},{"issue":"17","key":"4312_CR12","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.3390\/cancers14174069","volume":"14","author":"P Saiag","year":"2022","unstructured":"Saiag P, Molinier R, Roger A et al (2022) Efficacy of large use of combined Hypofractionated Radiotherapy in a cohort of Anti-PD-1 monotherapy-treated Melanoma patients. Cancers 14(17):4069. https:\/\/doi.org\/10.3390\/cancers14174069","journal-title":"Cancers"},{"key":"4312_CR13","doi-asserted-by":"publisher","first-page":"e425","DOI":"10.1016\/j.cllc.2020.06.001","volume":"22","author":"E Samuel","year":"2021","unstructured":"Samuel E, Lie G, Balasubramanian A et al (2021) Impact of Radiotherapy on the efficacy and toxicity of anti-PD-1 inhibitors in metastatic NSCLC. Clin Lung Cancer 22:e425\u2013e430","journal-title":"Clin Lung Cancer"},{"key":"4312_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40425-015-0095-8","volume":"3","author":"JD Schoenfeld","year":"2015","unstructured":"Schoenfeld JD, Mahadevan A, Floyd SR et al (2015) Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review. J Immunother Cancer 3:50","journal-title":"J Immunother Cancer"},{"key":"4312_CR15","doi-asserted-by":"publisher","first-page":"e813","DOI":"10.1016\/j.wneu.2020.09.082","volume":"144","author":"SA Singh","year":"2020","unstructured":"Singh SA, McDermott DM, Mattes MD (2020) Impact of systemic therapy type and timing on intracranial Tumor Control in patients with Brain Metastasis from Non-Small-Cell Lung Cancer treated with stereotactic radiosurgery. World Neurosurg 144:e813\u2013e823","journal-title":"World Neurosurg"},{"key":"4312_CR16","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.canrad.2022.04.005","volume":"26","author":"S Sumodhee","year":"2022","unstructured":"Sumodhee S, Guo L, Bouhlel L et al (2022) Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancer. Cancer Radiother 26:1045\u20131053","journal-title":"Cancer Radiother"},{"key":"4312_CR17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fphar.2019.00511","volume":"10","author":"M Trommer","year":"2019","unstructured":"Trommer M, Yeo SY, Persigehl T et al (2019) Abscopal effects in Radio-Immunotherapy-Response analysis of metastatic Cancer patients with Progressive Disease under Anti-PD-1 Immune Checkpoint Inhibition. Front Pharmacol 10:511","journal-title":"Front Pharmacol"},{"key":"4312_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ejca.2021.08.034","volume":"157","author":"Y Umeda","year":"2021","unstructured":"Umeda Y, Yoshikawa S, Kiniwa Y et al (2021) Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: a retrospective, multicenter study. Eur J Cancer 157:361\u2013372","journal-title":"Eur J Cancer"},{"key":"4312_CR19","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00432-021-03849-3","volume":"148","author":"P Wang","year":"2022","unstructured":"Wang P, Yin T, Zhao K et al (2022) Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer. J Cancer Res Clin Oncol 148:1253\u20131261","journal-title":"J Cancer Res Clin Oncol"},{"key":"4312_CR20","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","volume":"24","author":"SC Formenti","year":"2018","unstructured":"Formenti SC, Rudqvist N-P, Golden E et al (2018) Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat Med 24:1845\u20131851","journal-title":"Nat Med"},{"key":"4312_CR21","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.21873\/anticanres.15985","volume":"42","author":"Y Takayama","year":"2022","unstructured":"Takayama Y, Yano J, Seike R et al (2022) Efficacy of Chemoimmunotherapy in NSCLC Patients with Brain Metastasis with or without prior brain Radiotherapy. Anticancer Res 42:4805\u20134812","journal-title":"Anticancer Res"},{"key":"4312_CR22","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.2217\/fon-2020-0994","volume":"17","author":"DJ Craig","year":"2021","unstructured":"Craig DJ, Nanavaty NS, Devanaboyina M et al (2021) The abscopal effect of radiation therapy. Future Oncol 17:1683\u20131694","journal-title":"Future Oncol"},{"key":"4312_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri.2017.108","volume":"18","author":"AH Sharpe","year":"2018","unstructured":"Sharpe AH, Pauken KE (2018) The diverse functions of the PD1 inhibitory pathway. Nat Rev Immunol 18:153\u2013167","journal-title":"Nat Rev Immunol"},{"key":"4312_CR24","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2217\/imt-2019-0105","volume":"11","author":"E Garelli","year":"2019","unstructured":"Garelli E, Rittmeyer A, Putora PM et al (2019) Abscopal effect in lung cancer: three case reports and a concise review. Immunotherapy 11:1445\u20131461","journal-title":"Immunotherapy"},{"key":"4312_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejca.2020.03.006","volume":"132","author":"S Page","year":"2020","unstructured":"Page S, Milner-Watts C, Perna M et al (2020) Systemic treatment of brain metastases in non-small cell lung cancer. Eur J Cancer 132:187\u2013198","journal-title":"Eur J Cancer"},{"key":"4312_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3171\/2015.6.JNS142763","volume":"125","author":"RJ Colaco","year":"2016","unstructured":"Colaco RJ, Martin P, Kluger HM et al (2016) Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases? J Neurosurg 125:17\u201323","journal-title":"J Neurosurg"},{"key":"4312_CR27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W et al (2018) PRISMA Extension for scoping reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med 169:467\u2013473","journal-title":"Ann Intern Med"},{"key":"4312_CR28","doi-asserted-by":"crossref","unstructured":"Moola S, Munn Z, Tufanaru C et al (2020) Chap. 7: systematic reviews of etiology and risk. In: JBI Manual for evidence synthesis. JBI","DOI":"10.46658\/JBIRM-17-06"},{"key":"4312_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-020-03663-w","volume":"152","author":"RE Wegner","year":"2021","unstructured":"Wegner RE, Abel S, D\u2019Amico RS et al (2021) Time from stereotactic radiosurgery to immunotherapy in patients with melanoma brain metastases and impact on outcome. J Neurooncol 152:79\u201387","journal-title":"J Neurooncol"},{"key":"4312_CR30","doi-asserted-by":"publisher","first-page":"671044","DOI":"10.3389\/fonc.2021.671044","volume":"11","author":"M De Martino","year":"2021","unstructured":"De Martino M, Padilla O, Daviaud C et al (2021) Exploiting Radiation Therapy to restore Immune Reactivity of Glioblastoma. Front Oncol 11:671044","journal-title":"Front Oncol"},{"key":"4312_CR31","first-page":"vdac132","volume":"4","author":"DJ Pangal","year":"2022","unstructured":"Pangal DJ, Yarovinsky B, Cardinal T et al (2022) The abscopal effect: systematic review in patients with brain and spine metastases. Neurooncol Adv 4:vdac132","journal-title":"Neurooncol Adv"},{"key":"4312_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000510287","volume":"99","author":"MA D\u2019Andrea","year":"2021","unstructured":"D\u2019Andrea MA, Reddy GK (2021) Systemic Effects of Radiation Therapy-Induced Abscopal responses in patients with Advanced Lung Cancer. Oncology 99:1\u201314","journal-title":"Oncology"},{"key":"4312_CR33","doi-asserted-by":"publisher","first-page":"e557s","DOI":"10.6061\/clinics\/2018\/e557s","volume":"73","author":"H Carvalho","year":"2018","unstructured":"Carvalho H, de Villar A RC (2018) Radiotherapy and immune response: the systemic effects of a local treatment. Clinics 73:e557s","journal-title":"Clinics"},{"key":"4312_CR34","first-page":"e3777","volume":"10","author":"AJ Hamilton","year":"2018","unstructured":"Hamilton AJ, Seid J, Verdecchia K, Chuba P (2018) Abscopal Effect after Radiosurgery for Solitary Brain Metastasis from Non-small Cell Lung Cancer. Cureus 10:e3777","journal-title":"Cureus"},{"key":"4312_CR35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2034","author":"MV Galkin","year":"2018","unstructured":"Galkin MV, Golanov AV, Vetlova E et al (2018) Advanced survival in patients with multiple irradiations for brain melanoma metastases and associated abscopal effect. Cureus. https:\/\/doi.org\/10.7759\/cureus.2034","journal-title":"Cureus"},{"key":"4312_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13256-022-03321-x","volume":"16","author":"Y Ishikawa","year":"2022","unstructured":"Ishikawa Y, Umezawa R, Yamamoto T et al (2022) Differential abscopal effect in extracranial and intracranial lesions after radiotherapy alone for vertebral bone metastasis of unknown primary: a case report. J Med Case Rep 16:1\u201312","journal-title":"J Med Case Rep"},{"key":"4312_CR37","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","volume":"25","author":"RV Parry","year":"2005","unstructured":"Parry RV, Chemnitz JM, Frauwirth KA et al (2005) CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 25:9543\u20139553","journal-title":"Mol Cell Biol"},{"key":"4312_CR38","first-page":"601","volume":"25","author":"A Tarhini","year":"2010","unstructured":"Tarhini A, Lo E, Minor DR (2010) Releasing the brake on the immune system: ipilimumab in melanoma and other tumors. Cancer Biother Radiopharm 25:601\u2013613","journal-title":"Cancer Biother Radiopharm"},{"key":"4312_CR39","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.2147\/DDDT.S267433","volume":"14","author":"L Ai","year":"2020","unstructured":"Ai L, Chen J, Yan H et al (2020) Research Status and Outlook of PD-1\/PD-L1 inhibitors for Cancer Therapy. Drug Des Devel Ther 14:3625\u20133649","journal-title":"Drug Des Devel Ther"},{"key":"4312_CR40","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/cam4.140","volume":"2","author":"AW Silk","year":"2013","unstructured":"Silk AW, Bassetti MF, West BT et al (2013) Ipilimumab and radiation therapy for melanoma brain metastases. Cancer Med 2:899\u2013906","journal-title":"Cancer Med"},{"key":"4312_CR41","first-page":"1","volume":"26","author":"MJ Shepard","year":"2019","unstructured":"Shepard MJ, Xu Z, Donahue J et al (2019) Stereotactic radiosurgery with and without checkpoint inhibition for patients with metastatic non-small cell lung cancer to the brain: a matched cohort study. J Neurosurg 26:1\u20138","journal-title":"J Neurosurg"},{"key":"4312_CR42","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ijrobp.2017.11.041","volume":"100","author":"L Chen","year":"2018","unstructured":"Chen L, Douglass J, Kleinberg L et al (2018) Concurrent Immune checkpoint inhibitors and stereotactic radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and renal cell carcinoma. Int J Radiat Oncol Biol Phys 100:916\u2013925","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4312_CR43","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ijrobp.2016.01.054","volume":"95","author":"CJ Shen","year":"2016","unstructured":"Shen CJ, Kummerlowe MN, Redmond KJ et al (2016) Stereotactic radiosurgery: treatment of Brain Metastasis without interruption of systemic therapy. Int J Radiat Oncol Biol Phys 95:735\u2013742","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4312_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11060-017-2442-8","volume":"133","author":"JM Kim","year":"2017","unstructured":"Kim JM, Miller JA, Kotecha R et al (2017) The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies. J Neurooncol 133:357\u2013368","journal-title":"J Neurooncol"},{"key":"4312_CR45","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1001\/jamadermatol.2017.2222","volume":"153","author":"J Doyen","year":"2017","unstructured":"Doyen J, Picard A, Naghavi AO et al (2017) Clinical outcomes of metastatic melanoma treated with checkpoint inhibitors and Multisite Radiotherapy. JAMA Dermatol 153:1056\u20131059","journal-title":"JAMA Dermatol"},{"key":"4312_CR46","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1200\/JCO.2017.76.2229","volume":"36","author":"JJ Luke","year":"2018","unstructured":"Luke JJ, Lemons JM, Karrison TG et al (2018) Safety and clinical activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in patients with Advanced Solid Tumors. J Clin Oncol 36:1611\u20131618","journal-title":"J Clin Oncol"},{"key":"4312_CR47","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","volume":"372","author":"EB Garon","year":"2015","unstructured":"Garon EB, Rizvi NA, Hui R et al (2015) Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med 372:2018\u20132028","journal-title":"N Engl J Med"},{"key":"4312_CR48","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1200\/JCO.19.00934","volume":"37","author":"EB Garon","year":"2019","unstructured":"Garon EB, Hellmann MD, Rizvi NA et al (2019) Five-year overall survival for patients with Advanced non\u2013small-cell lung Cancer treated with Pembrolizumab: results from the phase I KEYNOTE-001 study. J Clin Oncol 37:2518\u20132527","journal-title":"J Clin Oncol"},{"key":"4312_CR49","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S2213-2600(18)30500-9","volume":"7","author":"NB Leighl","year":"2019","unstructured":"Leighl NB, Hellmann MD, Hui R et al (2019) Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study. Lancet Respir Med 7:347\u2013357","journal-title":"Lancet Respir Med"},{"key":"4312_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ijrobp.2020.06.057","volume":"108","author":"CA Helis","year":"2020","unstructured":"Helis CA, Hughes RT, Glenn CW et al (2020) Predictors of adverse Radiation Effect in Brain Metastasis Patients treated with stereotactic radiosurgery and Immune checkpoint inhibitor therapy. Int J Radiat Oncol Biol Phys 108:295\u2013303","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4312_CR51","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/jamaoncol.2017.3993","volume":"4","author":"AM Martin","year":"2018","unstructured":"Martin AM, Cagney DN, Catalano PJ et al (2018) Immunotherapy and Symptomatic Radiation necrosis in patients with brain metastases treated with Stereotactic Radiation. JAMA Oncol 4:1123\u20131124","journal-title":"JAMA Oncol"},{"key":"4312_CR52","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.radonc.2018.08.025","volume":"130","author":"EJ Lehrer","year":"2019","unstructured":"Lehrer EJ, Peterson J, Brown PD et al (2019) Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: an international meta-analysis of individual patient data. Radiother Oncol 130:104\u2013112","journal-title":"Radiother Oncol"},{"key":"4312_CR53","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11060-015-1881-3","volume":"125","author":"ZA Kohutek","year":"2015","unstructured":"Kohutek ZA, Yamada Y, Chan TA et al (2015) Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases. J Neurooncol 125:149\u2013156","journal-title":"J Neurooncol"},{"key":"4312_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02688697.2021.2022098","volume":"4","author":"S Badrigilan","year":"2022","unstructured":"Badrigilan S, Meola A, Chang SD et al (2022) Stereotactic radiosurgery with immune checkpoint inhibitors for brain metastases: a meta-analysis study. Br J Neurosurg 4:1\u201311","journal-title":"Br J Neurosurg"},{"key":"4312_CR55","doi-asserted-by":"publisher","first-page":"106148","DOI":"10.1016\/j.intimp.2019.106148","volume":"80","author":"L Yang","year":"2020","unstructured":"Yang L, Liu L, Wu X et al (2020) Hypofractionated radiation therapy with versus without immune checkpoint inhibitors in patients with brain metastases: a meta-analysis. Int Immunopharmacol 80:106148","journal-title":"Int Immunopharmacol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04312-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04312-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04312-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T17:06:38Z","timestamp":1685552798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04312-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,22]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["4312"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04312-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,22]]},"assertion":[{"value":"8 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}